Global Narcotic (Opioid) Drugs Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Narcotic (Opioid) Drugs Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Codeine
  • 1.4.3 Fentanyl
  • 1.4.4 Hydrocodone
  • 1.4.5 Hydromorphone
  • 1.4.6 Meperidine
  • 1.4.7 Methadone
  • 1.4.8 Others
• 1.5 Market by Application
  • 1.5.1 Global Narcotic (Opioid) Drugs Market Share by Application: 2020 VS 2026
  • 1.5.2 Pain Relief Application
  • 1.5.3 Anesthesia Application
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Narcotic (Opioid) Drugs Market Perspective (2015-2026)
• 2.2 Narcotic (Opioid) Drugs Growth Trends by Regions
  • 2.2.1 Narcotic (Opioid) Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Narcotic (Opioid) Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Narcotic (Opioid) Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Narcotic (Opioid) Drugs Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Narcotic (Opioid) Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Narcotic (Opioid) Drugs Players by Market Size
  • 3.1.1 Global Top Narcotic (Opioid) Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Narcotic (Opioid) Drugs Market Concentration Ratio
  • 3.2.1 Global Narcotic (Opioid) Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Narcotic (Opioid) Drugs Revenue in 2019
• 3.3 Narcotic (Opioid) Drugs Key Players Head office and Area Served
• 3.4 Key Players Narcotic (Opioid) Drugs Product Solution and Service
• 3.5 Date of Enter into Narcotic (Opioid) Drugs Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Narcotic (Opioid) Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2021-2026)

5 Narcotic (Opioid) Drugs Breakdown Data by Application (2015-2026)

• 5.1 Global Narcotic (Opioid) Drugs Market Size by Application (2015-2020)
• 5.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Narcotic (Opioid) Drugs Market Size (2015-2020)
• 6.2 Narcotic (Opioid) Drugs Key Players in North America (2019-2020)
• 6.3 North America Narcotic (Opioid) Drugs Market Size by Type (2015-2020)
• 6.4 North America Narcotic (Opioid) Drugs Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Narcotic (Opioid) Drugs Market Size (2015-2020)
• 7.2 Narcotic (Opioid) Drugs Key Players in Europe (2019-2020)
• 7.3 Europe Narcotic (Opioid) Drugs Market Size by Type (2015-2020)
• 7.4 Europe Narcotic (Opioid) Drugs Market Size by Application (2015-2020)

8 China

• 8.1 China Narcotic (Opioid) Drugs Market Size (2015-2020)
• 8.2 Narcotic (Opioid) Drugs Key Players in China (2019-2020)
• 8.3 China Narcotic (Opioid) Drugs Market Size by Type (2015-2020)
• 8.4 China Narcotic (Opioid) Drugs Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Narcotic (Opioid) Drugs Market Size (2015-2020)
• 9.2 Narcotic (Opioid) Drugs Key Players in Japan (2019-2020)
• 9.3 Japan Narcotic (Opioid) Drugs Market Size by Type (2015-2020)
• 9.4 Japan Narcotic (Opioid) Drugs Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Narcotic (Opioid) Drugs Market Size (2015-2020)
• 10.2 Narcotic (Opioid) Drugs Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Narcotic (Opioid) Drugs Market Size by Type (2015-2020)
• 10.4 Southeast Asia Narcotic (Opioid) Drugs Market Size by Application (2015-2020)

11 India

• 11.1 India Narcotic (Opioid) Drugs Market Size (2015-2020)
• 11.2 Narcotic (Opioid) Drugs Key Players in India (2019-2020)
• 11.3 India Narcotic (Opioid) Drugs Market Size by Type (2015-2020)
• 11.4 India Narcotic (Opioid) Drugs Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Narcotic (Opioid) Drugs Market Size (2015-2020)
• 12.2 Narcotic (Opioid) Drugs Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Narcotic (Opioid) Drugs Market Size by Type (2015-2020)
• 12.4 Central & South America Narcotic (Opioid) Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Pfizer
  • 13.1.1 Pfizer Company Details
  • 13.1.2 Pfizer Business Overview and Its Total Revenue
  • 13.1.3 Pfizer Narcotic (Opioid) Drugs Introduction
  • 13.1.4 Pfizer Revenue in Narcotic (Opioid) Drugs Business (2015-2020))
  • 13.1.5 Pfizer Recent Development
• 13.2 Teva
  • 13.2.1 Teva Company Details
  • 13.2.2 Teva Business Overview and Its Total Revenue
  • 13.2.3 Teva Narcotic (Opioid) Drugs Introduction
  • 13.2.4 Teva Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 13.2.5 Teva Recent Development
• 13.3 Purdue Pharma
  • 13.3.1 Purdue Pharma Company Details
  • 13.3.2 Purdue Pharma Business Overview and Its Total Revenue
  • 13.3.3 Purdue Pharma Narcotic (Opioid) Drugs Introduction
  • 13.3.4 Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 13.3.5 Purdue Pharma Recent Development
• 13.4 Mallinckrodt
  • 13.4.1 Mallinckrodt Company Details
  • 13.4.2 Mallinckrodt Business Overview and Its Total Revenue
  • 13.4.3 Mallinckrodt Narcotic (Opioid) Drugs Introduction
  • 13.4.4 Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 13.4.5 Mallinckrodt Recent Development
• 13.5 Amneal Pharma
  • 13.5.1 Amneal Pharma Company Details
  • 13.5.2 Amneal Pharma Business Overview and Its Total Revenue
  • 13.5.3 Amneal Pharma Narcotic (Opioid) Drugs Introduction
  • 13.5.4 Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 13.5.5 Amneal Pharma Recent Development
• 13.6 Collegium
  • 13.6.1 Collegium Company Details
  • 13.6.2 Collegium Business Overview and Its Total Revenue
  • 13.6.3 Collegium Narcotic (Opioid) Drugs Introduction
  • 13.6.4 Collegium Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 13.6.5 Collegium Recent Development
• 13.7 Johnson & Johnson
  • 13.7.1 Johnson & Johnson Company Details
  • 13.7.2 Johnson & Johnson Business Overview and Its Total Revenue
  • 13.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Introduction
  • 13.7.4 Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 13.7.5 Johnson & Johnson Recent Development
• 13.8 Merck
  • 13.8.1 Merck Company Details
  • 13.8.2 Merck Business Overview and Its Total Revenue
  • 13.8.3 Merck Narcotic (Opioid) Drugs Introduction
  • 13.8.4 Merck Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 13.8.5 Merck Recent Development
• 13.9 Mylan
  • 13.9.1 Mylan Company Details
  • 13.9.2 Mylan Business Overview and Its Total Revenue
  • 13.9.3 Mylan Narcotic (Opioid) Drugs Introduction
  • 13.9.4 Mylan Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 13.9.5 Mylan Recent Development
• 13.10 Hikma Pharmaceuticals
  • 13.10.1 Hikma Pharmaceuticals Company Details
  • 13.10.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
  • 13.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Introduction
  • 13.10.4 Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 13.10.5 Hikma Pharmaceuticals Recent Development
• 13.11 Sun Pharma
  • 10.11.1 Sun Pharma Company Details
  • 10.11.2 Sun Pharma Business Overview and Its Total Revenue
  • 10.11.3 Sun Pharma Narcotic (Opioid) Drugs Introduction
  • 10.11.4 Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 10.11.5 Sun Pharma Recent Development
• 13.12 Endo Pharmaceuticals
  • 10.12.1 Endo Pharmaceuticals Company Details
  • 10.12.2 Endo Pharmaceuticals Business Overview and Its Total Revenue
  • 10.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Introduction
  • 10.12.4 Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 10.12.5 Endo Pharmaceuticals Recent Development
• 13.13 Allergan
  • 10.13.1 Allergan Company Details
  • 10.13.2 Allergan Business Overview and Its Total Revenue
  • 10.13.3 Allergan Narcotic (Opioid) Drugs Introduction
  • 10.13.4 Allergan Revenue in Narcotic (Opioid) Drugs Business (2015-2020)
  • 10.13.5 Allergan Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer